Pfizer (PFE)
(Delayed Data from NYSE)
$27.98 USD
+0.18 (0.65%)
Updated Jun 28, 2024 04:01 PM ET
After-Market: $27.93 -0.05 (-0.18%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Brokerage Reports
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 121 - 140 ( 565 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 122122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 121122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 12122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 11/18/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended November 18.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 112122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 111122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 11122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 21.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 10/21/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 14.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 10/14/22
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 102122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 101122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 10122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 23.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D